Login to Your Account



Earnings Roundup

Solid Quarter for Celgene; Revlimid Sales up 39%

By Catherine Shaffer


Friday, April 29, 2011

Celgene Corp. CEO Robert Hugin opened Thursday morning's conference call with, "It was an excellent quarter for Celgene," and indeed it was.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription